The use of phentolamine in the prevention of dopamine-induced tissue extravasation

Journal of Critical Care

Volumn 13, Issue 1, 1998, Pages 13-20

  Bey, Donna ^b   El Chaar, Gladys M ^a   Bierman, Fredrick ^b   Valderrama, Elsa ^b  

^a ST JOHN'S UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; PHENTOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL MIGRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; ERYTHEMA; EXTRAVASATION; FASCIA; HEMATOMA; MAST CELL DEGRANULATION; MUSCLE; NEUTROPHIL; NONHUMAN; PALLOR; RANDOMIZED CONTROLLED TRIAL; RAT; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TISSUE INJURY;

EID: 0031946221     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-9441(98)90024-7     Document Type: Article

References (23)

1. Driscoll DJ, Pinsky WW, Entman ML: How to use inotropic drugs in children. Drug Ther 9:124-135, 1979
2. DiSessa TG, Leitner M, Ti CC, et al: The cardiovascular effects of dopamine in the severely asphyxiated neonate. J Pediatr 99:772-776, 1981
3. Lang P, Williams RG, Norwood WI, et al: The hemodynamic effects of dopamine in infants after corrective cardiac surgery. J Pediatr 96:630-634, 1980
4. Greenlaw CW, Mull LW: Dopamine-induced ischemia. Lancet 2:555, 1977
5. Greene SI, Smith JW: Dopamine gangrene. N Engl J Med 294:114, 1976
6. Alexander CS, Sako Y, Mikulic E: Pedal gangrene associated with the use of dopamine. N Engl J Med 293:591, 1975
7. Lynch DJ, Key JC, White RR: Management and prevention of infiltration and extravasation injury. Surg Clin North Am 59:939-949, 1979
8. Koerber RK, Haven GT, Cohen SM, et al: Peripheral gangrene associated with dopamine infusion in a child. Clin Pediatr 23:106-107, 1984
9. Maggi JC, Angelats J, Scott JP: Gangrene in a neonate following dopamine therapy. J Pediatr 100:323-325, 1982
10. Denkler KA, Cohen BE: Reversal of dopamine extravasation injury with topical nitroglycerin ointment. Plast Reconstr Surg 84:811-813, 1989
11. Siwy BK, Sadove AM: Acute management of dopamine infiltration injury with Regitine. Plast Reconstr Surg 80:610-612, 1987
12. Zucker G: Use of phentolamine to prevent necrosis due to levarterenol. JAMA 163:1477-1479, 1957
13. Aycock BG, Hawtof DB, Moody SB: Treatment of peripheral ischemia secondary to lidocaine containing epinephrine. Annals of Plastic Surgery 23:27-30, 1989
14. Product Information: Levophed (norepinephrine), 1995
15. Hastings-Tolsma M, Yucha CB: IV infiltration. No clear signs, no clear treatment? Registered Nurse 12:34-38, 1994
16. Hill JM: Phentolamine mesylate: The antidote for vasopressor extravasation. Crit Care Nurse 11:58-61, 1990
17. Scachner LA: Pediatric Dermatology. New York, Churchill-Livingstone, 1988
18. Gaze NR: Tissue necrosis caused by commonly used intravenous solutions. Lancet 2:417-419, 1978
19. Ebels T, Van der Heide JNH: Dopamine-induced ischemia. Lancet 2:762, 1977
20. Lynch DJ, Key JC, White RR: Management and prevention of infiltration and extravasation injury. Surg Clin North Am 59:939-949, 1979
21. Goodman LS, Gilman A, Goodman LS (eds): The Pharmacological Basis of Therapeutics. New York, Macmillan, 1985
22. Product Information: Regitine (Phentolamine), 1995
23. Flemmer L, Chan JSL: A pediatric protocol for the management of extravasation injuries. Pediatric Nursing, 19:355-358, 1993